Skip to content
2000
Volume 18, Issue 17
  • ISSN: 1568-0266
  • E-ISSN: 1873-4294

Abstract

Background: A series of symmetrical 1,4-disubstituted bis-1,2,3-triazoles was prepared by double copper catalyzed Azide-alkyne Cycloaddition (CuAAC) from aliphatic bis-azides and a tetraethylene glycol bis-azide derivative. The eighteen novel compounds were evaluated in vitro for their cytotoxic activity against two human tumor cell lines: Human breast adenocarcinoma (MDA-MB 231) and ovarian adenocarcinoma (TOV-21G). Results and Conclusion: The results of colorimetric MTT assays showed that compounds 4j and 4q exhibited a better selectivity index and cell viability comparable with the standard drug doxorubicin. These compounds induced apoptosis in both tested cell lines, as assessed by BrdU assay. The results suggest that these structurally simple compounds may be promising prototypes for antitumoral agents.

Loading

Article metrics loading...

/content/journals/ctmc/10.2174/1568026618666181022124847
2018-07-01
2025-07-12
Loading full text...

Full text loading...

/content/journals/ctmc/10.2174/1568026618666181022124847
Loading

  • Article Type:
    Research Article
Keyword(s): Apoptosis; Bis-azides; BrdU; Cancer; Cytotoxicity; Double CuAAC; Symmetrical bis-1,2,3-triazoles
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test